Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-03-03 @ 5:14 AM
Study NCT ID:
NCT00964002
Status:
COMPLETED
Last Update Posted:
2022-05-16
First Post:
2009-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efavirenz in Treating Patients With Metastatic Prostate Cancer
Sponsor:
Institut Bergonié
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000641767
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None